(Q34486393)

2 August 2017

title

SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma (English)

1 reference

2 August 2017

1 reference

1 reference

5

Thomas Krausz

1 reference

2 August 2017

Gergő Papp

1

1 reference

2 August 2017

Yi-Che Changchien

2

1 reference

2 August 2017

Bálint Péterfia

3

1 reference

2 August 2017

Loránd Pecsenka

4

1 reference

2 August 2017

Thomas P Stricker

6

1 reference

2 August 2017

Andras Khoor

7

1 reference

2 August 2017

Ludvik Donner

8

1 reference

2 August 2017

Zoltán Sápi

9

1 reference

2 August 2017

publication date

23 November 2012

1 reference

2 August 2017

1 reference

2 August 2017

volume

26

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

393-403

1 reference

Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

The SWI/SNF complex and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

INI1-deficient tumors: diagnostic features and molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Epithelioid sarcoma.A sarcoma simulating a granuloma or a carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Gene-promoter hypermethylation as a biomarker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Roles of the EZH2 histone methyltransferase in cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

7 January 2021

Histone deacetylase 1 and 2 in mesenchymal tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

7 January 2021

Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

7 January 2021

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.190

1 reference

7 January 2021

10.1038/MODPATHOL.2012.190

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1052421434

0 references

1 reference